These alterations led to a significant increase in the CD8+ T-cell-to-Treg ratio in pancreatic cancer (Fig. 5f), suggesting an amplification of CD8+ T-cell-specific antitumour immunity. The gene discussed is CD8A; the disease is pancreatic neoplasm.